These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23803055

  • 1. FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.
    Zhu SH, Zhang Y, Yu YH, Fu Z, Kong L, Han DL, Fu L, Yu JM, Li J.
    Asian Pac J Cancer Prev; 2013; 14(5):2925-9. PubMed ID: 23803055
    [Abstract] [Full Text] [Related]

  • 2. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A.
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 4. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ, MacRae R, Sirisegaram A, Pantarotto JR.
    Int J Radiat Oncol Biol Phys; 2014 Feb 01; 88(2):312-8. PubMed ID: 24411602
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Feb 01; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
    Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, Nakata M.
    Ann Nucl Med; 2015 Dec 01; 29(10):854-60. PubMed ID: 26254228
    [Abstract] [Full Text] [Related]

  • 8. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
    Kurtipek E, Çayci M, Düzgün N, Esme H, Terzi Y, Bakdik S, Aygün MS, Unlü Y, Burnik C, Bekci TT.
    Clin Nucl Med; 2015 Jun 01; 40(6):459-63. PubMed ID: 25742234
    [Abstract] [Full Text] [Related]

  • 9. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
    Li M, Liu N, Hu M, Shi F, Yuan S, Zhang P, Fu Z, Yang G, Yu J.
    Lung Cancer; 2009 Mar 01; 63(3):383-6. PubMed ID: 18635284
    [Abstract] [Full Text] [Related]

  • 10. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G, Rahouma M, Kamel MK, Nasar A, Harrison S, Nguyen AB, Port J, Stiles BM, Altorki NK, Lee PC.
    Ann Thorac Surg; 2017 Oct 01; 104(4):1153-1158. PubMed ID: 28551047
    [Abstract] [Full Text] [Related]

  • 11. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb 01; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 01; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
    Tanaka H, Hayashi S, Hoshi H.
    Asia Pac J Clin Oncol; 2016 Mar 01; 12(1):e113-7. PubMed ID: 24176011
    [Abstract] [Full Text] [Related]

  • 14. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
    Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.
    Clin Nucl Med; 2009 Apr 01; 34(4):216-21. PubMed ID: 19300050
    [Abstract] [Full Text] [Related]

  • 15. Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer: 18F-FDG PET/CT Study.
    Morbelli S, Alama A, Ferrarazzo G, Coco S, Genova C, Rijavec E, Bongioanni F, Biello F, Dal Bello MG, Barletta G, Massollo M, Vanni I, Piva R, Nieri A, Bauckneht M, Sambuceti G, Grossi F.
    J Nucl Med; 2017 Nov 01; 58(11):1764-1769. PubMed ID: 28450567
    [Abstract] [Full Text] [Related]

  • 16. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.
    Lim CH, Ahn TR, Moon SH, Cho YS, Choi JY, Kim BT, Lee KH.
    Eur Radiol; 2019 Apr 01; 29(4):1903-1911. PubMed ID: 30315418
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T, Choi WH, Hyun J, Kim SH, Chung SK, Yoo IeR.
    J Med Assoc Thai; 2014 Feb 01; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [Abstract] [Full Text] [Related]

  • 18. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S, Bilfinger TV, Komaroff E, Franceschi D.
    Clin Lung Cancer; 2005 Mar 01; 6(5):310-3. PubMed ID: 15845183
    [Abstract] [Full Text] [Related]

  • 19. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [Abstract] [Full Text] [Related]

  • 20. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J, Thureau S, Dubray B, Modzelewski R, Thiberville L, Gardin I, Vera P.
    J Nucl Med; 2015 Feb 01; 56(2):196-203. PubMed ID: 25572091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.